- VeChain is helping fight counterfeit medicine by verifying drugs using blockchain.
- Its development activity has surged 520 percent and it now holds an EU MiCAR license for regulatory compliance.
VeChain has emerged as a vital tool in the fight against counterfeit medicine, offering real-time product verification and supply chain transparency. According to the World Health Organization (WHO), more than 100,000 people die each year from the consumption of fake drugs, which means the solution to reliable tracking sources has become urgent.
In a recent post, VeChain ambassador Sebastian.vet points out the severe gaps in global health logistics, not in delivery but in proof. Although there is global access to medicine, many countries don’t have the infrastructure to verify the validity of each vial. VeChain directly addresses those needs with QR-linked identities, tamper-proof logs, and cold chain scoring systems to ensure product integrity from production to patient.
He noted,
“The World Health Organization can distribute vaccines. But it can’t verify every dose. #VeChain can.”
Although the WHO has the ability to distribute vaccines, it is unable to ensure their effectiveness. VeChain is in production, providing that missing proof layer. However, it’s still within those medical grade standards and is compliant with GDPR and GxP. These qualities are a fit for both public and private use cases without the need to run in a speculative or token-enabled environment.
VeChain and WHO Create a Layer of Global Trust
The post asserts that VeChain doesn’t compete with the WHO, it powers its efforts. The WHO delivers the medicine, but VeChain delivers the proof. They’ve collaboratively built up what Sebastian.vet calls a ‘first global immune system for supply chain trust.’
“This Isn’t About Crypto Adoption. It’s About Human Survival. A single verified vial can mean.”
Sebastian.vet
Unlike every other crypto venture that is about the hype, VeChain is silently working in the background, saving lives and not being spoiled about price speculation tokens. The infrastructure allows for instantaneous traceability and real-time tracking at global verifiability and provides an easy-to-deploy solution to combating life-threatening problems.
VeChain’s narrative is known to improve the humanitarian front, drawing institutional attention to the technology. According to Crypto News Flash, VeChain development activity skyrocketed by 520%, overtaking BNB Chain, Hedera, and Algorand.
Regulators have not gone blind to the growing credibility of the blockchain. Earlier this month, VeChain became one of the first enterprise-focused networks to hold a MiCAR (Markets in Crypto-Assets Regulation) license in compliance with the new EU regulatory framework.
Market Signals Remain Strong as Price Holds Key Support
VeChain’s native token, VET, has regained momentum as the broader crypto market recovers. The cryptocurrency is trading at $0.02820, marking a daily gain of 0.04% and raising its market capitalization above $2.42 billion. Renewed investor interest has seen trading volume also up by 4% to over $42 million.
On the daily chart, VeChain’s VET token forms an inverse head and shoulders formation, indicating a bullish breakout. According to CryptoBusy, the asset is testing the neckline around $0.0278.
The next upward move could triggered if a breakout above this level were to come off successfully. Resistance is weakening after weeks of consolidation, and the structure shows that momentum is growing. CryptoBusy noted, “once we clear the neckline, the next leg up is imminent for vechain.”
Credit: Source link
